Pharmaceutical Manufacturing and Formulation

This contract involves the manufacturing and formulation of Sulfamethoxazole and Trimethoprim tablets according to USP specifications. The scope includes sourcing the active pharmaceutical ingredients (APIs), as well as the processes of blending, tablet compression, and comprehensive quality control testing to ensure product compliance and effectiveness. The contract is identified as a subcontract under the NAICS code 325412, which relates to pharmaceutical manufacturing. The Department of Defense, through the Medical Supply Chain Pharm FSA, is the contracting agency overseeing this effort. The manufacturing work is to be performed at Fort Campbell, with the postal code 42223-5000. The contract has a posted date of May 20, 2026, with a response deadline set for six days later on May 26, 2026. This timeline indicates a relatively urgent procurement process, emphasizing prompt submission of proposals for the supply of these essential pharmaceutical products.